A Study of Recombinant Human Growth Hormone Injection for Short Children With Small for Small for Gestational Age(SGA)

Clinical trial NCT03245333 · UNKNOWN

Trial details

NCT number: NCT03245333
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Small for Gestational Age Infant

Start date: 2014-12-01
Primary completion: 2017-12-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.